“decrease distributed program”的搜索结果，显示 291-300 项，共有 838 项
Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...
... reduce progression of PD disability. PLS Natural History Study. Rochester ... Diagnosing Craniosynostosis MR with Facial Recognition Software. Rochester ...
Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...
... lower colorectal cancer risk (6,7). Diet may affect cytokine levels and ... decrease the risk of colon cancer in an UK study (12). Recently, the EDII ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Top 5 lifestyle changes to reduce cholesterol. 一份馈赠，无穷力量——今天就来伸出援手！ 慷慨捐赠. 您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护 ...
The Neuro-Oncology Program Registry and Biobank will be used for research purposes to increase our understanding of nervous system tumors. A Registry for ...
The purpose of thisstudy is to evaluate reduction of radiotherapy dose for patients with indolent NHL by conducting a prospective randomized phase 2 study ...
Diagnosing Craniosynostosis MR with Facial Recognition Software ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic ...
... reduce progression of PD disability. PLS Natural ... Diagnosing Craniosynostosis MR with Facial Recognition Software ... decline (e.g., Mueller et al, 2018).
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。